InsiderSignal.AI

InsiderSignal.ai

COSM - Cosmos Health Inc.

Insider Purchase by Siokas Grigorios (CEO, 10%)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

1 month ago, Siokas Grigorios, serving as CEO, 10% owner at Cosmos Health Inc. (COSM), purchased 113,185 shares at $0.50 per share, for a total transaction value of $57,000.00. Following this transaction, Siokas Grigorios now holds 7,244,979 shares of COSM.

This purchase represents a 2.00% increase in Siokas Grigorios's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, January 12, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, January 13, 2026, 1 day after the trade was made.

Cosmos Health Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DISTRIBUTION industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Siokas Grigorios

Siokas Grigorios

CEO, 10%

Grigorios (Greg) Siokas is a Person and serves as Chief Executive Officer, director, and 10% owner of Cosmos Health Inc. (NASDAQ: COSM), a diversified global healthcare group.[[2]](https://fintool.com/app/research/companies/COSM/people/grigorios-siokas)[[7]](https://www.gurufocus.com/insider/110768/grigorios-siokas) He has led Cosmos Health as CEO and director since 2016, briefly holding a dual role as acting Chief Financial Officer until November 11, 2020, and has been a central figure in the company’s strategic growth, capital structure management, and international expansion.[[2]](https://fintool.com/app/research/companies/COSM/people/grigorios-siokas) A significant insider holder, Siokas directly owns roughly 7 million Cosmos Health shares and has repeatedly converted personal loans to the company into equity, underlining his financial commitment and alignment with shareholders.[[1]](https://www.investing.com/news/insider-trading-news/cosmos-health-ceo-siokas-buys-65000-in-cosm-stock-93CH-4437729)[[7]](https://www.gurufocus.com/insider/110768/grigorios-siokas)[[8]](https://www.tradingview.com/news/tradingview:b9810913fa3aa:0-cosmos-health-ceo-converts-debt-to-equity/) Siokas brings over 15 years of pharmaceutical industry experience, notably as CEO and operations manager of SkyPharm S.A., a Cosmos subsidiary focused on European medicine exports, and as a long‑time major shareholder in several Greek pharmaceutical distribution companies, including Ippokratis, Thrakis, Thessalias, and ZED Pharma.[[2]](https://fintool.com/app/research/companies/COSM/people/grigorios-siokas) His background combines scientific and financial training: he holds a Bachelor’s degree in Geology from Aristotle University of Thessaloniki and a Master’s degree in management and finance from the Universities of Stuttgart and Tübingen.[[2]](https://fintool.com/app/research/companies/COSM/people/grigorios-siokas)

View full insider profile →

Trade Price

$0.50

Quantity

113,185

Total Value

$57,000.00

Shares Owned

7,244,979

Trade Date

Monday, January 12, 2026

41 days ago

SEC Filing Date

Tuesday, January 13, 2026

Filed 1 day after trade

HEALTHCAREMEDICAL DISTRIBUTION

About Cosmos Health Inc.

Company Overview

No company information available
View news mentioning COSM

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3068199

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime